RECURSION PHARMACEUTICALS, INC. - RXRX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q4 2025 · Q3 2025

Value (USD)

Total reported value ($000)

$1.38B

QoQ value delta ($000)

-$191.9M (-12.21%)

Implied price effect (QoQ)

-16.18%

Total shares

337,492,456

QoQ shares delta

+15,268,812 (+4.74%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Early Q1 2026 data: only 21 institutional holders reported so far. More will appear as funds file with the SEC.

Manager	Value ($000)	Shares	% of 13F
VANGUARD GROUP INC	192,997	47,187,759	0.0%
BlackRock, Inc.	158,965	38,866,779	0.0%
ARK Investment Management LLC	152,625	37,316,856	1.01%
STATE STREET CORP	103,615	25,333,888	0.0%
BAILLIE GIFFORD & CO	97,239	23,774,972	0.08%
SOFTBANK GROUP CORP.	55,773	13,636,515	0.36%
GEODE CAPITAL MANAGEMENT, LLC	44,731	10,934,252	0.0%
MIC Capital Management UK LLP	39,444	9,644,032	8.94%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	37,064	9,062,204	0.0%
CITADEL ADVISORS LLC	33,433	8,174,399	0.01%
Sumitomo Mitsui Trust Group, Inc.	25,443	6,221,025	0.01%
Amova Asset Management Americas, Inc.	25,381	6,221,025	0.29%
Data Collective IV GP, LLC	24,299	5,941,120	41.53%
NORGES BANK	23,472	5,739,064	0.0%
MORGAN STANLEY	23,139	5,657,578	0.0%
Lingotto Investment Management LLP	20,168	4,931,057	0.35%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	16,667	4,075,219	0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	16,338	3,994,651	0.0%
DCVC Opportunity Fund II GP, LLC	16,160	3,951,141	97.43%
UBS Group AG	15,276	3,735,174	0.0%
NORTHERN TRUST CORP	14,069	3,439,949	0.0%
FMR LLC	13,259	3,241,892	0.0%
TWO SIGMA INVESTMENTS, LP	12,577	3,075,123	0.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd	9,832	2,404,118	0.68%
FIRST TRUST ADVISORS LP	9,270	2,266,691	0.01%